Results: Liver Cancer

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Afp ***
Hr **
Stat3 **
Hccs **
Bax *
Cck *
Foxk1 *
Runx3 *
Igfbp1 *
Polr2e *
Cdca5 *
Dlx6 *
Kif20a *
Usp22 *
Pin1 *
Sav1 *
C5orf30 *
Ccnh *
Mad2l1 *
Mtor *
Sgk3 *
Pes1 *
Ccna2 *
Xrcc1 *
Gdf15 *
Hspa4 *
Myc *
Lats2 *
Glul *
Hspa1b *
Grn *
Cxcr3 *
Pdcd1 n.s.
Sirt6 n.s.
Aldoa n.s.
Fer n.s.
Gpc3 n.s.
Map3k7 n.s.
Nqo1 n.s.
Ccnb2 n.s.
Chek1 n.s.
Arg1 n.s.
Twist1 n.s.
Mmp7 n.s.
Pi3 n.s.
Fen1 n.s.
Cps1 n.s.
Hmox1 n.s.
Pdk1 n.s.
Srf n.s.
Proc n.s.
Akr1b10 n.s.
Aes n.s.
Sry n.s.
Mri n.s.
Mst1 n.s.
Sox9 n.s.
Taz n.s.
Casp3 n.s.
Cd44 n.s.
Hras n.s.
Pkm n.s.
Ctnnb1 n.s.
Xiap n.s.
Cyp2e1 n.s.
E2f1 n.s.
Mlkl n.s.
Zeb1 n.s.
Met n.s.
Tsc1 n.s.
Cd14 n.s.
Mvd n.s.
Fgf19 n.s.
Hgf n.s.
Abca1 n.s.
Smad2 n.s.
Foxm1 n.s.
Cpt2 n.s.
Ide n.s.
Nup155 n.s.
Ftsj1 n.s.
Pgs1 n.s.
Crls1 n.s.
Vnn3 n.s.
Alb n.s.
Ldhb n.s.
Mt1g n.s.
Mt1h n.s.
Pdcl n.s.
Atp2a3 n.s.
Otc n.s.
Mef2d n.s.
Dec1 n.s.
Dyrk2 n.s.
Nr1d2 n.s.
Cmtm7 n.s.
Rpia n.s.
Cklf n.s.
Rit1 n.s.
Nr3c2 n.s.

Top Ranked Key Phrases

Barcelona clinic liver cancer stage ***
Non alcoholic fatty liver disease ***
Hepatitis b virus hbv infection ***
Hepatitis c virus hcv infection ***
Nonalcoholic fatty liver disease nafld ***
Liver cancer stem cells lcscs ***
Hepatitis b virus infection ***
Hepatitis b virus hbv ***
Nonalcoholic fatty liver disease ***
Hepatitis c virus hcv ***
Epithelial mesenchymal transition emt ***
Liver cancer stem cells ***
Cancer stem cells cscs ***
Liver cancer cell lines ***
Human liver cancer cells ***
Cancer related death worldwide ***
Cancer related deaths worldwide ***
Advanced hepatocellular carcinoma hcc ***
Common primary liver cancer ***
Primary liver cancer plc ***
Hepatitis b virus ***
Hepatocellular carcinoma hcc patients ***
Magnetic resonance imaging ***
Non alcoholic steatohepatitis ***
Cell cycle arrest **
Chronic hepatitis b **
Long term survival **
Cancer cell lines **
Kaplan meier method **
Hcc cell lines **
Log rank test **
Child pugh score **
G0 g1 phase **
Hepatocellular carcinoma cells **
Mitochondrial membrane potential **
Nonalcoholic steatohepatitis nash **
Dose dependent manner **
Advanced hepatocellular carcinoma **
Chronic hbv infection **
Human liver cancer **
Chronic liver disease **
Wnt Β catenin pathway **
Primary liver cancer **
Child pugh class **
Transarterial chemoembolization tace **
Alpha fetoprotein afp **
Hepatocellular carcinoma hcc **
Mhcc97 l psuper **
Including liver cancer **
Independent prognostic factor **
Cell cycle progression **
Cancer death worldwide **
Liver cancer cells **
Western blot analysis **
Liver cancer tissues **
Treating liver cancer *
Liver cancer therapy *
Chronic liver diseases *
Overall survival os *
95% confidence intervals cis *
Hcc cell proliferation *
Early stage hcc *
Hepatocellular carcinoma patients *
Liver cancer risk *
Protein expression levels *
Potential therapeutic target *
Present study was *
Liver cancer progression *
Liver cancer treatment *
Intrahepatic cholangiocarcinoma icc *
Independent risk factors *
Radiofrequency ablation rfa *
Study was conducted *
Liver cancer development *
Liver cancer patients *
Second leading cause *
Cell lines n.s.
95% confidence interval ci n.s.
Hepatitis b n.s.
Hepatitis c n.s.
Fatty liver n.s.
Nf Κb n.s.
Cell cycle n.s.
Viral hepatitis n.s.
Hepatocellular carcinoma n.s.
Present study aimed n.s.
Transarterial chemoembolization n.s.
Bclc b n.s.
Present study investigated n.s.

Top Ranked Mesh Terms

Female ***
Retrospective studies ***
Epidemiology ***
Aged ***
Apoptosis ***
Drug therapy ***
Mice nude ***
Chemistry ***
Carcinoma hepatocellular ***
Mice ***
Treatment outcome ***
Biomarkers tumor ***
Genetics ***
Male ***
Cell line tumor ***
Adult ***
Cell proliferation ***
Aged 80 and over ***
Pathology ***
Antineoplastic agents ***
Cell movement ***
Liver ***
Metabolism ***
Mortality ***
Methods ***
Signal transduction ***
Prognosis ***
Animals ***
Hep g2 cells ***
Humans ***
Middle aged ***
Pharmacology ***
Gene expression regulation neoplastic ***
Liver neoplasms ***
Neoplasm staging ***
Up-regulation ***
Risk factors ***
Young adult ***
Xenograft model antitumor assays ***
Diagnosis **
Liver cirrhosis **
Micrornas **
Cell survival **
Chemoembolization therapeutic **
Mice inbred balb c **
Neoplasm invasiveness **
Rna long noncoding **
Kaplan-meier estimate **
Carcinogenesis **
Disease progression **
Survival analysis **
Follow-up studies **
Hepatectomy **
Rna small interfering **
Virology **
Hepatocytes **
Tomography x-ray computed **
Down-regulation **
Cell cycle **
Survival rate **
Neoplasm recurrence local **
Neoplastic stem cells **
Incidence **
Neoplasms **
Dna methylation **
Hepatitis b **
Diagnostic imaging **
Doxorubicin **
Hepatitis b virus **
Hepacivirus **
Gene knockdown techniques **
China **
Stat3 transcription factor **
Dose-response relationship drug **
Hepatitis c **
Neoplasm metastasis **
Combined modality therapy *
Radiotherapy dosage *
Cell cycle checkpoints *
Nanoparticles *
Tumor cells cultured *
Non-alcoholic fatty liver disease *
Embolization therapeutic *
Magnetic resonance imaging *
Rna messenger *
Map kinase signaling system *
Cholangiocarcinoma *
Antiviral agents *
Plant extracts *
Proto-oncogene proteins c-akt *
Prevalence *
Wnt signaling pathway *
Molecular docking simulation *
Cohort studies *
Drug delivery systems *
Bile duct neoplasms *
Liver diseases *
Hepatitis b chronic *
Microspheres *
Methyltransferases *

Results for: Liver Cancer

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes